166 related articles for article (PubMed ID: 129288)
1. [Detection of antibodies against Coxsackie A, B and Echo viruses in human sera by the method of two-dimensional immunodiffusion on agar gel. I. Precipitating antibodies against Coxackie viruses group B].
Dupková E
Cesk Epidemiol Mikrobiol Imunol; 1975 Sep; 24(5):270-4. PubMed ID: 129288
[No Abstract] [Full Text] [Related]
2. [Inactivated combined Coxsackie A-9 and B-1 as well as Echo-6 vaccine. II. Immunogenicity of the combined vaccine].
Biernacki M; Jabloński L
Med Dosw Mikrobiol; 1974; 26(4):347-50. PubMed ID: 4475337
[No Abstract] [Full Text] [Related]
3. [Quick antiserum preparation for the virus CF-test. Immunisation of rats with enteroviruses (ECHO and Coxsackie) and respiratory syncytial (RS) viruses].
Adam D
Zentralbl Bakteriol Orig; 1970 May; 213(4):470-8. PubMed ID: 5455470
[No Abstract] [Full Text] [Related]
4. [Sensitive virologic evaluation in suspected meningitis: study of a radioimmunotest for the detection of IgM antibodies against ECHO 9 and ECHO 11 viruses].
Burkhardt F; Reigel F; Schilt U
Schweiz Med Wochenschr; 1983 Jun; 113(25):902-9. PubMed ID: 6612271
[TBL] [Abstract][Full Text] [Related]
5. [Antibodies against enterovirus (ECHO virus 7, 11, 12 and coxsackie virus B 3) of the inhabitants of Okinawa and South-Western islands in Pacific ocean].
Higashi T
Kumamoto Igakkai Zasshi; 1971 May; 45(5):588-624. PubMed ID: 5171705
[No Abstract] [Full Text] [Related]
6. Enterovirus immunodiffusion reactions: a comparison of results obtained in agarose and agar using two different microdiffusion systems.
Styk B; Schmidt NJ
J Immunol; 1968 Jun; 100(6):1223-9. PubMed ID: 4972185
[No Abstract] [Full Text] [Related]
7. Distribution of antibodies against Coxsackie B viruses, arboviruses and Toxoplasma gondii among patients with endomyocardial fibrosis (EMF) compared with normal subjects from EMF endemic and non-endemic zones of Nigeria.
Ijaola O; Falase AO
Afr J Med Med Sci; 1990 Jun; 19(2):93-103. PubMed ID: 2165348
[TBL] [Abstract][Full Text] [Related]
8. [Age distribution of neutralizing antibodies against Coxsackie and ECHO viruses among inhabitants of the Morioka area].
Kawana R; Kaneko M
Igaku To Seibutsugaku; 1965 Dec; 71(6):373-7. PubMed ID: 5895001
[No Abstract] [Full Text] [Related]
9. Acquisition of antibodies to various Coxsackie and Echo viruses and hepatitis A virus in agricultural communal settlements in Israel.
Morag A; Margalith M; Shuval HI; Fattal B
J Med Virol; 1984; 14(1):39-47. PubMed ID: 6747611
[TBL] [Abstract][Full Text] [Related]
10. [Immunity response of 3 animal species (guinea pigs, hamsters, mice) to various Coxsackie viruses of group A. II. Study of antibodies detected by gel immunodiffusion: comparison with complement fixing antibodies].
Bringuier JP; Gaudin OG; Brigaud M; Terraillon J; Sohier R
Ann Inst Pasteur (Paris); 1971 Oct; 121(4):551-61. PubMed ID: 5004043
[No Abstract] [Full Text] [Related]
11. Indirect enzyme-linked immunosorbent assay (ELISA) for detection of IgG antibodies against Coxsackie B viruses.
Hannington G; Booth JC; Wiblin CN; Stern H
J Med Microbiol; 1983 Nov; 16(4):459-65. PubMed ID: 6315943
[TBL] [Abstract][Full Text] [Related]
12. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
[TBL] [Abstract][Full Text] [Related]
13. Counter-electrophoresis as a possible method for typing ECHO and Coxsackie B viruses.
MacWilliam KM; Cook KM
J Hyg (Lond); 1975 Apr; 74(2):239-44. PubMed ID: 1054727
[TBL] [Abstract][Full Text] [Related]
14. [Changes in antibody titers against an enterovirus (ECHO 22) in North Bavaria in relation to mortality from heart disease 1977 to 1981].
Moldenhauer D
Zentralbl Bakteriol Mikrobiol Hyg B; 1984 Jan; 178(5-6):502-9. PubMed ID: 6326426
[TBL] [Abstract][Full Text] [Related]
15. [Does virus diagnosis open new ways for the classification and treatment of sudden deafness, unilateral vestibular loss and idiopathic facial paralysis?].
Leitner C
HNO; 1986 Sep; 34(9):376-8. PubMed ID: 3771296
[TBL] [Abstract][Full Text] [Related]
16. [The value of the Coxsackie B virus complement fixation test (author's transl)].
Hofmann H
Wien Klin Wochenschr; 1975 Dec; 87(24):819-22. PubMed ID: 1226771
[TBL] [Abstract][Full Text] [Related]
17. Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65).
Vreugdenhil GR; Batstra MR; Aanstoot HJ; Melchers WJ; Galama JM
J Med Virol; 1999 Oct; 59(2):256-61. PubMed ID: 10459165
[TBL] [Abstract][Full Text] [Related]
18. [Persistence of latex-agglutination inhibiting and neutralizing antibodies against enterovirus in the healthy population (author's transl)].
Schmidt WA; Brade H; Klein M; Krämer U
Dtsch Med Wochenschr; 1975 Aug; 100(33):1663-6. PubMed ID: 169112
[TBL] [Abstract][Full Text] [Related]
19. [Antibody levels against coxsackie B viruses in patients with type 1 diabetes mellitus].
Emekdaş G; Rota S; Kuştimur S; Kocabeyoğlu O
Mikrobiyol Bul; 1992 Apr; 26(2):116-20. PubMed ID: 1316989
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiological background of transient hyperphosphatasemia].
Suzuki M; Okazaki T; Asahara M; Kadohno N; Kanno T
Rinsho Byori; 1998 Jan; 46(1):88-90. PubMed ID: 9492545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
